Shopping Cart
- Remove All
 
Your shopping cart is currently empty
UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | $2,258 | 8-10 weeks | |
| 50 mg | $2,980 | 8-10 weeks | |
| 100 mg | $4,000 | 8-10 weeks | 
| Description | UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay.  | 
| Targets&IC50 |  PAR4:(kd)1.4 nM, PAR4:4 nM  | 
| Molecular Weight | 513.56 | 
| Formula | C28H23N3O5S | 
| Cas No. | 1477497-01-0 | 
| Relative Density. | 1.36 g/cm3 (Predicted) | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.